Clinical trials: sponsored by Fox Chase Cancer Center
Lung Cancer, Small-cell Lung Cancer
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
This is an open-label, non-randomized, single-center, phase II study to evaluate the efficacy, toxicity and, tolerability of pre-specified dose attenuated chemotherapy regimens in lung cancer patients with comorbidities.
- Conditions
- Lung Cancer, Small-cell Lung Cancer, Non Small Cell Lung Cancer
- Trial name
- NCT05800587
- Testing
- Carboplatin, Pemetrexed, Paclitaxel
- Where
- United States
- Volunteers
- 280 people
- Sponsor
- Fox Chase Cancer Center
Solid Tumor
Phase I Study in Advanced Malignancies With 5-ALA
RDT aims to take advantage of the relatively safer toxicity profiles of both lower dose radiation therapy and systemic ALA to treat non-superficial lesions in a manner similar to photodynamic therapy.
- Trial name
- NCT04381806
- Testing
- 5-ALA
- Where
- United States
- Volunteers
- 130 people
- Sponsor
- Fox Chase Cancer Center
Urothelial Carcinoma of the Bladder
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
The aim of this study is to evaluate a risk-adapted approach to the treatment of muscle invasive bladder cancer. Each baseline transuretheral resection of bladder tumor (TURBT) sample will be sequenced while proceeding with…
- Trial name
- NCT02710734
- Testing
- Methotrexate, Vinblastine, Doxorubicin
- Where
- 4 sites in United States
- Volunteers
- 78 people
- Sponsor
- Fox Chase Cancer Center
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
While cigarette smoking remains the primary cause of most lung cancer cases, lung carcinoma in never smokers account for nearly 20 percent of cases.
- Trial name
- NCT03786692
- Testing
- Arm A, Arm B
- Where
- United States
- Volunteers
- 107 people
- Sponsor
- Fox Chase Cancer Center
Anemia
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
This is an open-label, single institution study evaluating the efficacy of intravenous iron sucrose monotherapy in patients with thoracic, breast, GU and GI malignancies undergoing neoadjuvant chemotherapy with the goal of…
- Trial name
- Iron-RANC (NCT05800600)
- Testing
- Venofer
- Where
- United States
- Volunteers
- 34 people
- Sponsor
- Fox Chase Cancer Center
Renal Cell Carcinoma, Urothelial Carcinoma
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
This is a comparative study using resected/ biopsied tumors samples collected from renal cell carcinoma and urothelial carcinoma patients who underwent surgical removal of lesions, followed by immune checkpoint blockade (ICB)…
- Conditions
- Renal Cell Carcinoma, Urothelial Carcinoma, Bladder Cancer, Ureter Cancer
- Trial name
- NCT03291028
- Testing
- Immune checkpoint inhibitor targeting PD1
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Fox Chase Cancer Center
Pancreatic Cancer
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer
Standard chemoradiation, followed by surgery are standard treatment plan for patients suffering from pancreatic adenocarcinoma. Due to damage to the surrounding healthy tissue caused by standard radiation, this study uses a new…
- Trial name
- NCT04452357
- Testing
- PLDR
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Fox Chase Cancer Center
Pancreatic Ductal Adenocarcinoma
PHL Treatment in Pancreatic Cancer
This proposal will investigate the effect of paricalcitol, hydroxychloroquine, and losartan (PHL) combination of 3 stroma-modifying drugs on pancreatic adenocarcinoma and its stroma.
- Trial name
- NCT05365893
- Testing
- Paricalcitol, Hydroxychloroquine, Losartan, Neoadjuvant therapy and surgery only (Control)
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Fox Chase Cancer Center
Rectal Cancer
Organ Preservation in Early Rectal Cancer Patients
This is a single arm phase II study of neoadjuvant chemotherapy followed by local excision and post-operative chemoradiotherapy in patients with early stage, low rectal adenocarcinoma.
- Trial name
- NCT03548961
- Testing
- FOLFOX regimen
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- Fox Chase Cancer Center
Squamous Cell Carcinoma of Head and Neck
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
The goal of this clinical trial is to learn if drug CADI-05, when used together with pembrolizumab (an FDA approved immunotherapy), can help treat locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in adults.
- Trial name
- NCT07455032
- Testing
- intradermal injection of CADI-05, Pembrolizumab
- Where
- 2 sites in United States
- Volunteers
- 22 people
- Sponsor
- Fox Chase Cancer Center
Uterine Cervical Neoplasms
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
This is a randomized trial to evaluate the effects of a community-based intervention on increasing cervical cancer screening rates in underserved Asian American (Korean, Vietnamese, and Chinese) women.
- Trial name
- NCT04557423
- Testing
- Community-Based Education, Navigation to Screening, HPV Self-Sampling
- Where
- United States
- Volunteers
- 797 people, healthy volunteers welcome
- Sponsor
- Fox Chase Cancer Center
Urothelial Carcinoma, Metastatic Urothelial Carcinoma
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
This is a non-randomized two arm open-label phase 2 pilot study in adult subjects with locally advanced or metastatic urothelial cancer.
- Conditions
- Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma
- Trial name
- NCT05923190
- Testing
- Enfortumab vedotin, Pembrolizumab
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Fox Chase Cancer Center
Bladder Cancer, Patient Engagement
Recovery Support for Bladder Cancer Patients and Caregivers
For patients with certain types of bladder cancer, the removal of the bladder and the construction of an artificial bladder or reservoir are the only treatment options.
- Conditions
- Bladder Cancer, Patient Engagement, Patient Empowerment, Ileal Conduit
- Trial name
- NCT04055311
- Testing
- Cancer Resource Information Support (CRIS), Usual Care Enhanced
- Where
- 2 sites in United States
- Volunteers
- 174 people
- Sponsor
- Northwell Health
Cancer
Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)
The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test results.
- Trial name
- eREACH3 (NCT07471958)
- Where
- United States
- Volunteers
- 360 people, healthy volunteers welcome
- Sponsor
- Abramson Cancer Center at Penn Medicine
Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy
A Study Looking at a New Nerve Surgery to Help Men Regain Erections After Prostate Cancer Surgery
A single arm prospective pilot trial evaluating the 1-year erectile recovery outcomes and the safety of patients undergoing a somatic to autonomic nerve grafting procedure for restoration of erectile function in patients who have…
- Trial name
- PRP NG PRO M (NCT07188064)
- Testing
- Post radical prostatectomy nerve restoration procedure (PRP-NR)
- Where
- Canada
- Volunteers
- 100 people
- Sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
Pulmonary Nodule, Multiple, Pulmonary Nodule, Solitary
Utility of CAML as Diagnostic for Early Stage Lung Cancer
Primary Objective Determine the prevalence of CAMLS in patients with pulmonary nodules. Secondary Objectives Determine the positive and negative predictive value of CAMLS in patients with pulmonary nodules who undergo biopsy.
- Trial name
- NCT03992183
- Where
- 2 sites in United States
- Volunteers
- 200 people
- Sponsor
- Fox Chase Cancer Center
Metastatic Urothelial Carcinoma, Unresectable Urothelial Carcinoma
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line Metastatic Urothelial Carcinoma
This is a single-arm, open-label, non-randomized Phase II trial evaluating the efficacy of induction therapy with enfortumab vedotin (EV) plus pembrolizumab (P) for 18 weeks (6 cycles), followed by maintenance pembrolizumab in…
- Conditions
- Metastatic Urothelial Carcinoma, Unresectable Urothelial Carcinoma, Advanced Urothelial Carcinoma
- Trial name
- IMPROEV (NCT07221942)
- Testing
- Enfortumab vedotin, Pembrolizumab
- Where
- United States
- Volunteers
- 97 people
- Sponsor
- Fox Chase Cancer Center
Multiple Myeloma
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
In this research study, we are looking to explore the drug combination, lenalidomide, bortezomib and dexamethasone alone or when combined with autologous stem cell transplantation to see what side effects it may have and how well…
- Trial name
- DFCI 10-106 (NCT01208662)
- Testing
- Lenalidomide, Bortezomib, Dexamethasone
- Where
- 46 sites in United States
- Volunteers
- 729 people
- Sponsor
- Paul Richardson, MD
Neoplasm
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
The overarching goal of the current study is to reduce the burden Asian American patients may feel are on their caregivers by designing and testing the feasibility and efficacy of a positive activity intervention designed to…
- Trial name
- CARE (NCT06782581)
- Testing
- Contribution to Caregivers Well-Being, Control
- Where
- United States
- Volunteers
- 186 people, healthy volunteers welcome
- Sponsor
- Fox Chase Cancer Center
Rectum Cancer, Adenocarcinoma
Adaptive Radiation Boost for Rectal Cancer
The goal of this clinical trial is to find out if giving extra adaptive radiation therapy after standard chemoradiation treatment is safe and helpful for people with rectal cancer.
- Trial name
- ARBOR (NCT07221058)
- Testing
- Adaptive Radiotherapy Boost
- Where
- United States
- Volunteers
- 37 people
- Sponsor
- Fox Chase Cancer Center